DT
HealthMore in Health→
New RNA Target Could Strengthen EGFR Drug Strategies Against Glioblastoma
Researchers say a newly identified long non-coding RNA appears to drive glioblastoma growth alongside EGFR amplification, opening a possible path to make EGFR-directed treatments work better.
Key Takeaways
- Researchers linked a novel long non-coding RNA to glioblastoma cell growth.
- The RNA acts alongside EGFR amplification, a change seen in more than half of glioblastoma tumors.
DE
DT Editorial Team··via medicalxpress.com